Filing Flows › Comparisons › ELAN vs BMRN
Elanco Animal Health vs BioMarin Pharmaceutical: ELAN and BMRN compared
Elanco Animal Health is the larger company: $1.3B of revenue in its latest quarter (Q3 2026) against $1.0B for BioMarin Pharmaceutical (Q3 2026). BioMarin Pharmaceutical is growing faster (+32% against +11% a year earlier). Elanco Animal Health is more profitable, with an operating margin of 1.9% against -8.0%.
Where the money goes: ELAN and BMRN
Elanco Animal Health (ELAN) · Q3 2026
Elanco Animal Health, Q3 2026: revenue $1.3B (+11% year over year), operating margin 1.9%, net earnings $18.0M, operating cash flow $216M. The chart follows the revenue to costs, profit and cash.
BioMarin Pharmaceutical (BMRN) · Q3 2026
BioMarin Pharmaceutical, Q3 2026: revenue $1.0B (+32% year over year), operating margin -8.0%, net loss $123M, operating cash flow $188M. The chart follows the revenue to costs, profit and cash.
| Elanco Animal Health (ELAN) | BioMarin Pharmaceutical (BMRN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.3B | $1.0B |
| Revenue growth, Y/Y | +11% | +32% |
| Gross margin | 56.9% | — |
| Operating margin | 1.9% | -8.0% |
| Net earnings | $18.0M | −$123M |
| Net margin | 1.4% | -12.0% |
| Operating cash flow | $216M | $188M |
| Free cash flow | $156M | $160M |
| Market value | $13.1B | $10.8B |
| Analysts’ mean target | $30.69 | $90.78 |
Where the revenue comes from
Elanco Animal Health
- Farm Animal:: $631M (50%)
- Pet Health: $608M (48%)
- Contract Manufacturing: $26.0M (2%)
BioMarin Pharmaceutical
- Net product revenues: $1.0B (99%)
- Royalty and other revenues: $11.6M (1%)
Questions
Which is bigger, Elanco Animal Health or BioMarin Pharmaceutical?
Elanco Animal Health is the larger company: $1.3B of revenue in its latest quarter (Q3 2026) against $1.0B for BioMarin Pharmaceutical (Q3 2026).
Is Elanco Animal Health or BioMarin Pharmaceutical growing faster?
BioMarin Pharmaceutical is growing faster (+32% against +11% a year earlier).
Which is more profitable, Elanco Animal Health or BioMarin Pharmaceutical?
Elanco Animal Health is more profitable, with an operating margin of 1.9% against -8.0%.
More: Elanco Animal Health earnings · how Elanco Animal Health makes money · BioMarin Pharmaceutical earnings · how BioMarin Pharmaceutical makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.